Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers.

Laronga C, Becker S, Watson P, Gregory B, Cazares L, Lynch H, Perry RR, Wright GL Jr, Drake RR, Semmes OJ.

Dis Markers. 2003-2004;19(4-5):229-38.

2.

Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.

Becker S, Cazares LH, Watson P, Lynch H, Semmes OJ, Drake RR, Laronga C.

Ann Surg Oncol. 2004 Oct;11(10):907-14.

PMID:
15383419
3.

Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.

Chung L, Moore K, Phillips L, Boyle FM, Marsh DJ, Baxter RC.

Breast Cancer Res. 2014 Jun 16;16(3):R63. doi: 10.1186/bcr3676.

4.
5.

Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling.

Gast MC, van Dulken EJ, van Loenen TK, Kingma-Vegter F, Westerga J, Flohil CC, Knol JC, Jimenez CR, van Gils CH, Wessels LF, Schellens JH, Beijnen JH.

Int J Biol Markers. 2009 Jul-Sep;24(3):130-41.

PMID:
19787623
6.

Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS.

Lei L, Wang XJ, Zheng ZG, Huang J, Cao WM, Chen ZH, Shao XY, Cai JF, Ye WW, Lu HY.

Anat Rec (Hoboken). 2011 Jun;294(6):941-4. doi: 10.1002/ar.21399.

7.

Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.

Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC Jr, Schraff S, Semmes OJ, Wadsworth JT, Drake RR.

Laryngoscope. 2008 Jan;118(1):61-8.

PMID:
18043497
8.

SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis.

Cheng L, Zhou L, Tao L, Zhang M, Cui J, Li Y.

J Cancer Res Clin Oncol. 2008 Jul;134(7):769-76. doi: 10.1007/s00432-007-0344-4.

PMID:
18202856
9.
10.

Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.

Lu HB, Zhou JH, Ma YY, Lu HL, Tang YL, Zhang QY, Zhao CH.

Jpn J Clin Oncol. 2010 Apr;40(4):336-42. doi: 10.1093/jjco/hyp175.

PMID:
20089528
12.

Application of serum SELDI proteomic patterns in diagnosis of lung cancer.

Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, Chen G, He DC.

BMC Cancer. 2005 Jul 20;5:83.

13.

Serum inflammatory protein profiles in patients with chronic rhinosinusitis undergoing sinus surgery: a preliminary analysis.

Becker AM, Das S, Xia Z, Liu Z, Adam BL, Kountakis SE.

Am J Rhinol. 2008 Mar-Apr;22(2):139-43. doi: 10.2500/ajr.2008.22.3151.

PMID:
18416969
14.

[Application of serum proteomic mass spectrum analysis in breast cancer].

Ying MG, Chen Q, Ye YB, Chen HJ, Chen X, Zheng HY, Wu F.

Zhonghua Zhong Liu Za Zhi. 2010 Sep;32(9):698-702. Chinese.

PMID:
21122387
15.

SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.

Schwegler EE, Cazares L, Steel LF, Adam BL, Johnson DA, Semmes OJ, Block TM, Marrero JA, Drake RR.

Hepatology. 2005 Mar;41(3):634-42.

PMID:
15726646
16.

Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer.

Belluco C, Petricoin EF, Mammano E, Facchiano F, Ross-Rucker S, Nitti D, Di Maggio C, Liu C, Lise M, Liotta LA, Whiteley G.

Ann Surg Oncol. 2007 Sep;14(9):2470-6.

PMID:
17594124
18.

Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ.

Am J Clin Oncol. 2008 Apr;31(2):133-9. doi: 10.1097/COC.0b013e318145b98b.

PMID:
18391596
19.

Serum protein profile analysis in patients with head and neck squamous cell carcinoma.

Gourin CG, Xia ZS, Han Y, French AM, O'Rourke AK, Terris DJ, Adam BL.

Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):390-7.

PMID:
16618908
20.

Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).

Gast MC, van Gils CH, Wessels LF, Harris N, Bonfrer JM, Rutgers EJ, Schellens JH, Beijnen JH.

Clin Chem Lab Med. 2009;47(6):694-705. doi: 10.1515/CCLM.2009.151.

PMID:
19416081
Items per page

Supplemental Content

Support Center